Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway
about
Cdo binds Abl to promote p38alpha/beta mitogen-activated protein kinase activity and myogenic differentiationDynamics of the skeletal muscle secretome during myoblast differentiation.Gene expression profiling of the hyperplastic growth zones of the late trout embryo myotome using laser capture microdissection and microarray analysis.Role of Sema4C in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38alpha/beta MAPK activity and myogenic differentiationLrrc75b is a novel negative regulator of C2C12 myogenic differentiation.Tumor Necrosis Factor Alpha and Insulin-Like Growth Factor 1 Induced Modifications of the Gene Expression Kinetics of Differentiating Skeletal Muscle Cells.MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4CThe role of semaphorin3A in myogenic regeneration and the formation of functional neuromuscular junctions on new fibres.Erbin interacts with Sema4C and inhibits Sema4C-induced epithelial-mesenchymal transition in HK2 cells.The Roles of Mitogen-Activated Protein Kinase Pathways in TGF-β-Induced Epithelial-Mesenchymal Transition.Genomewide association analysis for average birth interval and stillbirth in swine.Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD.
P2860
Q24314378-8F1D80CB-D343-4329-939B-BBA7CEFB40BCQ34320724-C2B5A4EA-E351-4882-B84B-ECCC53A4BF96Q34622626-49E99028-A2DB-4CCF-AA11-B037B2E3146BQ34756991-815D1F7F-2CF2-4F42-B013-084D690BA5A9Q36817884-AA777CD7-07DF-482B-9164-BCD1090F9E28Q37341439-4EA53AB5-DEA7-45A3-B438-F6A5B7305363Q38829529-E050F9FE-2187-4CEF-B4F3-699F0EBB40C5Q38842997-FD63198C-1F82-4907-900B-79A9397F1678Q38863834-E35A15B3-049F-4F1D-9B97-4AC4A00A416AQ39076141-3AA5025F-201A-44EC-BF93-72CA43AE4FD8Q40867284-E14EBB44-26B6-4BCB-828A-47FE8A12E7E9Q40893664-6F8FC1A9-65A5-4C8E-A6F5-C5B80B4C7D48Q45758242-448A5787-B328-4424-812A-CF1016F7BB05
P2860
Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@ast
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@en
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@en-gb
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@nl
type
label
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@ast
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@en
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@en-gb
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@nl
prefLabel
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@ast
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@en
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@en-gb
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@nl
P2093
P921
P3181
P1476
Sema4C participates in myogeni ...... o through the p38 MAPK pathway
@en
P2093
Jiangang Yuan
Lingling Zhu
Shuhong Liu
Wenhong Fan
Xiaomin Wang
Xiaoping Chen
Xiaozhong Peng
P304
P3181
P356
10.1016/J.EJCB.2007.03.002
P407
P577
2007-06-01T00:00:00Z